These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30681295)

  • 1. Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America.
    Ibarra M; Dalla Costa T; Schaiquevich P; Cristofoletti R; Hernández González I; Fajardo-Robledo NS; Aragón Novoa M; Pecchio M; Cortinez I; Trocóniz IF; Romero-Tejeda EM
    CPT Pharmacometrics Syst Pharmacol; 2019 Apr; 8(4):197-200. PubMed ID: 30681295
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny.
    Corriol-Rohou S; Cheung SYA
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S112-S119. PubMed ID: 31502694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar and mimics: Latin America biosimilar regulations.
    Lizarraga A; Mysler E
    Int J Rheum Dis; 2019 Jan; 22(1):6-8. PubMed ID: 30689310
    [No Abstract]   [Full Text] [Related]  

  • 4. Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug Development.
    Hill-McManus D; Marshall S; Liu J; Willke RJ; Hughes DA
    Clin Pharmacol Ther; 2021 Jul; 110(1):49-63. PubMed ID: 32936931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model Informed Drug Development and Regulation in China: Challenges and Opportunities.
    Li L; Han H; Wang J; Wei C; Wang Y; Li M; Zhou Y; Yang J
    CPT Pharmacometrics Syst Pharmacol; 2019 Feb; 8(2):59-61. PubMed ID: 30407746
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent Advances in Drug Development and Regulatory Science in China.
    Chen J; Zhao N
    Ther Innov Regul Sci; 2018 Nov; 52(6):739-750. PubMed ID: 29714583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development.
    Gupta N; Bottino D; Simonsson USH; Musante CJ; Bueters T; Rieger TR; Macha S; Chenel M; Fancourt C; Kanodia J; Nayak S
    Clin Pharmacol Ther; 2020 Jun; 107(6):1285-1289. PubMed ID: 31709519
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Fit-For-Purpose Models for Regulatory Applications.
    Wang Y; Huang SM
    J Pharm Sci; 2019 Jan; 108(1):18-20. PubMed ID: 30244011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Pharmacology and Translational Aspects of Bispecific Antibodies.
    Trivedi A; Stienen S; Zhu M; Li H; Yuraszeck T; Gibbs J; Heath T; Loberg R; Kasichayanula S
    Clin Transl Sci; 2017 May; 10(3):147-162. PubMed ID: 28297195
    [No Abstract]   [Full Text] [Related]  

  • 10. Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
    Jamei M
    CPT Pharmacometrics Syst Pharmacol; 2020 Feb; 9(2):75-76. PubMed ID: 31905421
    [No Abstract]   [Full Text] [Related]  

  • 11. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
    Bai JPF; Earp JC; Pillai VC
    AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory density as a means to refine current regulatory approaches for increasingly complex medicines.
    Klein K; Stolk P; De Bruin ML; Leufkens H
    Drug Discov Today; 2021 Oct; 26(10):2221-2225. PubMed ID: 33862191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collaboration strategies for the Iberoamerican Cardiovascular Journals network].
    Márquez MF; Heras M; Del Pilar-Aguilar M; Alfonso F; Arai K; Barrero C; Belzeti C; Berman S; Coromoto N; Cuesta A; Guzmán I; Lombana BM; López Santi R; Lucas-Luciardi H; Macías W; Moreira F; Paniagua M; Pérez-de Isla L; Reyes Caorsi W; Salvati A
    Arch Cardiol Mex; 2011; 81(3):273-6. PubMed ID: 21975243
    [No Abstract]   [Full Text] [Related]  

  • 14. Can quantitative pharmacology improve productivity in pharmaceutical research and development?
    Patel M; Bueters T
    Expert Opin Drug Discov; 2020 Oct; 15(10):1111-1114. PubMed ID: 32511018
    [No Abstract]   [Full Text] [Related]  

  • 15. The consequences of 'Brexit' for drug discovery and development, and the regulatory implications.
    Golding BT; Waring MJ
    Expert Opin Drug Discov; 2018 Jul; 13(7):583-585. PubMed ID: 29634365
    [No Abstract]   [Full Text] [Related]  

  • 16. A survey on training in pediatric cardiopulmonary resuscitation in Latin America, Spain, and Portugal.
    López-Herce J; Carrillo A;
    Pediatr Crit Care Med; 2011 Sep; 12(5):e200-4. PubMed ID: 21057371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resuscitating Cardiovascular Drug Development.
    Helmy K; Harrington RA; Kocher B
    JAMA Cardiol; 2017 Dec; 2(12):1295-1296. PubMed ID: 29117283
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy coming of age in Latin America.
    Podhajcer O; Pitossi F; Agilar-Cordova E
    Mol Ther; 2002 Aug; 6(2):153-4. PubMed ID: 12186002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statement in favor of the foundation of the Iberoamerican Society for Medical Mycology].
    Quindós G; Pemán J
    Rev Iberoam Micol; 2017; 34(4):189-191. PubMed ID: 29132742
    [No Abstract]   [Full Text] [Related]  

  • 20. Reforming the Orphan Drug Act for the 21st Century.
    Sarpatwari A; Kesselheim AS
    N Engl J Med; 2019 Jul; 381(2):106-108. PubMed ID: 31291512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.